121 related articles for article (PubMed ID: 9590738)
1. [Expression and clinical significance of PCNA in renal pelvic and ureteral cancer].
Kong C; Li Z; Liu T
Zhonghua Wai Ke Za Zhi; 1996 Oct; 34(10):614-6. PubMed ID: 9590738
[TBL] [Abstract][Full Text] [Related]
2. [Clinical importance of p53 gene mutation and PCNA expression in ureteral and renal pelvic cancers].
Kong C; Liu T; Zhang M
Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):436-8. PubMed ID: 9387296
[TBL] [Abstract][Full Text] [Related]
3. [Recurrent urothelial cancer after resection of ureteral carcinoma].
Kong C; Ci J; Liu T
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):465-7. PubMed ID: 10920948
[TBL] [Abstract][Full Text] [Related]
4. [Post-operative recurrence patterns of urothelial tumors in the upper urinary tract: comparison between renal pelvic and ureteral tumors].
Sengiku A; Nishiyama H; Shimizu T; Watabe J; Soda T; Kamba T; Yoshimura K; Kanematsu A; Nakamura E; Kamoto T; Ogawa O
Hinyokika Kiyo; 2008 Nov; 54(11):703-9. PubMed ID: 19068723
[TBL] [Abstract][Full Text] [Related]
5. [Clinical studies on renal pelvic and ureteral tumors].
Yoshida T; Kajita Y; Iwaki H; Mori H; Yamauchi T
Hinyokika Kiyo; 2000 Feb; 46(2):77-81. PubMed ID: 10769793
[TBL] [Abstract][Full Text] [Related]
6. [Proliferating cell nuclear antigen expression as a prognostic indicator for renal cell carcinoma: comparison with pathologic features and DNA content].
Nakano S; Kawamura J
Hinyokika Kiyo; 1995 May; 41(5):343-8. PubMed ID: 7598033
[TBL] [Abstract][Full Text] [Related]
7. [A clinical study of renal pelvic and ureteral cancer associated with bladder cancer].
Sakaue K; Kakimoto K; Oda M; Kajikawa J; Koide T; Kobayashi Y
Hinyokika Kiyo; 1996 Feb; 42(2):91-4. PubMed ID: 8712094
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2009 Jun; 16(6):1494-500. PubMed ID: 19267156
[TBL] [Abstract][Full Text] [Related]
9. The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival.
Park J; Ha SH; Min GE; Song C; Hong B; Hong JH; Kim CS; Ahn H
J Urol; 2009 Sep; 182(3):894-9. PubMed ID: 19616243
[TBL] [Abstract][Full Text] [Related]
10. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
11. Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer.
Lyshchik A; Higashi T; Hara T; Nakamoto Y; Fujimoto K; Doi R; Imamura M; Saga T; Togashi K
Cancer Invest; 2007; 25(3):154-62. PubMed ID: 17530485
[TBL] [Abstract][Full Text] [Related]
12. [A clinical study of patients undergoing curative surgery for renal pelvic and ureteral cancers].
Takayama T; Nagata M; Unno T; Mugiya S; Hata M; Suzuki K; Fujita K
Hinyokika Kiyo; 2000 Mar; 46(3):155-9. PubMed ID: 10806570
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index.
Grignon DJ; Abdel-Malak M; Mertens W; Koster J; Keeney M; Sakr W; Shepherd RR
Mod Pathol; 1995 Jan; 8(1):18-24. PubMed ID: 7731937
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 and proliferating cell nuclear antigen (PCNA) expression correlates with subsequent local recurrence in nasopharyngeal carcinomas.
Tsai ST; Jin YT; Leung HW; Wang ST; Tsao CJ; Su IJ
Anticancer Res; 1998; 18(4B):2849-54. PubMed ID: 9713473
[TBL] [Abstract][Full Text] [Related]
15. [PCNA and Ki-67 expression in locally confined renal adenocarcinoma. Relationship with various histopathologic variables and prognostic significance].
Tejido Sánchez A; Sánchez Chapado M; Rosino Sánchez A; Passas Martínez J; Bethencourt Codes F; Ruiz Ramos P; Leiva Galvis O
Arch Esp Urol; 2002 Apr; 55(3):257-65. PubMed ID: 12068757
[TBL] [Abstract][Full Text] [Related]
16. [A clinical study of associated bladder cancer in patients with renal pelvic and ureteral cancer].
Togashi M; Toyota K; Kashiwagi A; Asano Y; Nagamori S; Seki T; Koyanagi T; Maru A
Hinyokika Kiyo; 1990 Oct; 36(10):1141-7. PubMed ID: 2264542
[TBL] [Abstract][Full Text] [Related]
17. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
[TBL] [Abstract][Full Text] [Related]
19. [Retrospective analysis of uroepithelial malignancies detected in the renal pelvis and ureter over the past decade at the Jikei University Hospital].
Ikemoto I; Shimomura T; Yamada H; Kimura T; Hasegawa T; Abe K; Oishi Y
Hinyokika Kiyo; 2003 Aug; 49(8):451-6. PubMed ID: 14518380
[TBL] [Abstract][Full Text] [Related]
20. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
